rethinkPeptides Search
Menu
Research citation

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.

Diabetes, obesity & metabolism, 24(8), 1553-1564

Citation

Wilding, John P H; Batterham, Rachel L; Davies, Melanie; Van Gaal, Luc F; Kandler, Kristian; Konakli, Katerina; Lingvay, Ildiko; McGowan, Barbara M; Oral, Tugce Kalayci; Rosenstock, Julio; Wadden, Thomas A; Wharton, Sean; Yokote, Koutaro; Kushner, Robert F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.. Diabetes, obesity & metabolism, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725